PSPN:SIXPSP Swiss Property AG Analysis
Data as of 2026-03-14 - not real-time
CHF 161.70
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The stock trades at CHF 161.7, just below its 20‑day SMA of 162.3 but comfortably above the 50‑day SMA of 155.2 and the 200‑day SMA of 143.4, indicating a bullish medium‑term bias. The RSI sits at 53.7, suggesting neutral momentum, while the MACD histogram is negative and the signal line exceeds the MACD line, a bearish technical cue that tempers the upward price bias. Volume is on an increasing trend, supporting the price advance, and the 30‑day volatility of 16.7% is moderate for a real‑estate stock. The market currently respects a support level near 156.2 and a resistance around 168.4, providing a clear trading range.
Fundamentally, PSPN’s trailing P/E of 18.1 is well below the industry average of 32.5, and the price‑to‑book of 1.31 signals a modest premium to net assets. The company delivered an 8.9% jump in FY25 net income to CHF 408.5 million, driven largely by property revaluations that offset flat rental income, while free cash flow of CHF 49.6 million underwrites a 2.46% dividend yield with a 44% payout ratio, suggesting sustainability. However, a debt‑to‑equity ratio of 59.8% and a forward P/E of 29.3 introduce leverage‑related risk, and operating margins, though high, have slipped slightly. Overall, the stock appears fairly valued with a blend of growth and income characteristics.
Fundamentally, PSPN’s trailing P/E of 18.1 is well below the industry average of 32.5, and the price‑to‑book of 1.31 signals a modest premium to net assets. The company delivered an 8.9% jump in FY25 net income to CHF 408.5 million, driven largely by property revaluations that offset flat rental income, while free cash flow of CHF 49.6 million underwrites a 2.46% dividend yield with a 44% payout ratio, suggesting sustainability. However, a debt‑to‑equity ratio of 59.8% and a forward P/E of 29.3 introduce leverage‑related risk, and operating margins, though high, have slipped slightly. Overall, the stock appears fairly valued with a blend of growth and income characteristics.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above 50‑day SMA but below 20‑day SMA
- Bearish MACD signal despite bullish trend
- Increasing volume supporting current price level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Trailing P/E well below industry average
- Attractive dividend yield with sustainable payout
- FY25 earnings growth of 8.9% driven by revaluations
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable asset base in Swiss office/commercial market
- Low beta indicating limited systematic risk
- Consistent dividend and moderate leverage
Key Metrics & Analysis
Financial Health
Revenue Growth-0.40%
Profit Margin116.36%
P/E Ratio18.1
ROE7.39%
ROA1.87%
Debt/Equity59.76
P/B Ratio1.3
Op. Cash FlowCHF227.2M
Free Cash FlowCHF49.6M
Industry P/E32.5
Technical Analysis
TrendBullish
RSI53.7
SupportCHF 156.20
ResistanceCHF 168.40
MA 20CHF 162.32
MA 50CHF 155.23
MA 200CHF 143.39
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target PriceCHF 152.00
Upside/Downside-6.00%
GradeFair
TypeBlend
Dividend Yield2.46%
Risk Assessment
Beta-0.08
Volatility16.74%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.